Skip Nav Destination
Issues
15 January 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Perspective
Cooperative Group Bulletin Board
New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting
Nancy D. Doolittle; Lauren E. Abrey; W. Archie Bleyer; Steven Brem; Thomas P. Davis; Paula Dore-Duffy; Lester R. Drewes; Walter A. Hall; John M. Hoffman; Agnieszka Korfel; Robert Martuza; Leslie L. Muldoon; David Peereboom; Darryl R. Peterson; Samuel D. Rabkin; Quentin Smith; Glen H.J. Stevens; Edward A. Neuwelt
Human Cancer Biology
Overexpression of Tropomysin-Related Kinase B in Metastatic Human Pancreatic Cancer Cells
Guido M. Sclabas; Shuichi Fujioka; Christian Schmidt; Zhongkui Li; Wayne A.I. Frederick; Wentao Yang; Kenji Yokoi; Douglas B. Evans; James L. Abbruzzese; Kenneth R. Hess; Wei Zhang; Isaiah J. Fidler; Paul J. Chiao
Fibroblast Growth Factor Receptor 3 Is Overexpressed in Urinary Tract Carcinomas and Modulates the Neoplastic Cell Growth
J. Javier Gómez-Román; Pilar Saenz; Jorge Cuevas González; Kepa Escuredo; Simon Santa Cruz; Corina Junquera; Laureano Simón; Antonio Martínez; J. Luis Gutiérrez Baños; Marta López-Brea; Clara Esparza; J. Fernando Val-Bernal
Identification of Gastric Cancer–Related Genes Using a cDNA Microarray Containing Novel Expressed Sequence Tags Expressed in Gastric Cancer Cells
Jeong-Min Kim; Ho-Yong Sohn; Sun Young Yoon; Jung-Hwa Oh; Jin Ok Yang; Joo Heon Kim; Kyu Sang Song; Seung-Moo Rho; Hyan Sook Yoo; Yong Sung Kim; Jong-Guk Kim; Nam-Soon Kim
Involvement of Chemokine Receptor 4/Stromal Cell–Derived Factor 1 System during Osteosarcoma Tumor Progression
Eliana Perissinotto; Giuliana Cavalloni; Francesco Leone; Valentina Fonsato; Stefania Mitola; Giovanni Grignani; Nadia Surrenti; Dario Sangiolo; Federico Bussolino; Wanda Piacibello; Massimo Aglietta
Imaging, Diagnosis, Prognosis
The Thioredoxin-1 Inhibitor 1-Methylpropyl 2-Imidazolyl Disulfide (PX-12) Decreases Vascular Permeability in Tumor Xenografts Monitored by Dynamic Contrast Enhanced Magnetic Resonance Imaging
Bénédicte F. Jordan; Matthew Runquist; Natarajan Raghunand; Robert J. Gillies; Wendy R. Tate; Garth Powis; Amanda F. Baker
Methylation of the γ-Catenin Gene Is Associated With Poor Prognosis of Renal Cell Carcinoma
Julia E. Breault; Hiroaki Shiina; Mikio Igawa; Leopoldo A. Ribeiro-Filho; Masao Deguchi; Hideki Enokida; Shinji Urakami; Masaharu Terashima; Masayuki Nakagawa; Christopher J. Kane; Peter R. Carroll; Rajvir Dahiya
Interlaboratory Comparability Study of Cancer Gene Expression Analysis Using Oligonucleotide Microarrays
Kevin K. Dobbin; David G. Beer; Matthew Meyerson; Timothy J. Yeatman; William L. Gerald; James W. Jacobson; Barbara Conley; Kenneth H. Buetow; Mervi Heiskanen; Richard M. Simon; John D. Minna; Luc Girard; David E. Misek; Jeremy M.G. Taylor; Samir Hanash; Katsuhiko Naoki; D. Neil Hayes; Christine Ladd-Acosta; Steven A. Enkemann; Agnes Viale; Thomas J. Giordano
Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients
Nádia Aparecida Bérgamo; Luciana Caricati da Silva Veiga; Patricia Pintor dos Reis; Inês Nobuko Nishimoto; José Magrin; Luiz Paulo Kowalski; Jeremy A. Squire; Sílvia Regina Rogatto
Loss of p16 Protein Defines High-Risk Patients with Gastrointestinal Stromal Tumors: A Tissue Microarray Study
Regine Schneider-Stock; Carsten Boltze; Jerzy Lasota; Brigitte Peters; Chris L. Corless; Petra Ruemmele; Luigi Terracciano; Matthias Pross; Luigi Insabato; Dolores Di Vizio; Igor Iesalnieks; Stefan Dirnhofer; Arndt Hartmann; Michel Heinrich; Markku Miettinen; Albert Roessner; Luigi Tornillo
Cancer Therapy: Clinical
A Phase I and Pharmacokinetic Study of Ecteinascidin-743 (Yondelis) in Children with Refractory Solid Tumors. A Children's Oncology Group Study
Loretta Lau; Jeffery G. Supko; Susan Blaney; Linda Hershon; Nita Seibel; Mark Krailo; Wenchun Qu; David Malkin; Jose Jimeno; Mark Bernstein; Sylvain Baruchel; for the Children's Oncology Group
Pharmacodynamic Analysis of Target Inhibition and Endothelial Cell Death in Tumors Treated with the Vascular Endothelial Growth Factor Receptor Antagonists SU5416 or SU6668
Darren W. Davis; Ryan Takamori; Chandrajit P. Raut; Henry Q. Xiong; Roy S. Herbst; Walter M. Stadler; John V. Heymach; George D. Demetri; Asif Rashid; Yu Shen; Sijin Wen; James L. Abbruzzese; David J. McConkey
Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial
Giorgio V. Scagliotti; Cornelius Kortsik; Graham G. Dark; Allan Price; Christian Manegold; Rafael Rosell; Mary O'Brien; Patrick M. Peterson; Daniel Castellano; Giovanni Selvaggi; Silvia Novello; Johannes Blatter; Louis Kayitalire; Lucio Crino; Luis Paz-Ares
Cancer Therapy: Preclinical
Sequential Immunogene Therapy with Interleukin-12– and Interleukin-15–Engineered Neuroblastoma Cells Cures Metastatic Disease in Syngeneic Mice
Michela Croce; Raffaella Meazza; Anna Maria Orengo; Luana Radic'; Barbara De Giovanni; Claudio Gambini; Barbara Carlini; Vito Pistoia; Lorenzo Mortara; Roberto S. Accolla; Maria Valeria Corrias; Silvano Ferrini
Adenoviral Transduction of TESTIN Gene into Breast and Uterine Cancer Cell Lines Promotes Apoptosis and Tumor Reduction In vivo
Manuela Sarti; Cinzia Sevignani; George A. Calin; Rami Aqeilan; Masayoshi Shimizu; Francesca Pentimalli; Maria Cristina Picchio; Andrew Godwin; Anne Rosenberg; Alessandra Drusco; Massimo Negrini; Carlo M. Croce
Sustained Tumor Regression of Human Colorectal Cancer Xenografts Using a Multifunctional Mannosylated Fusion Protein in Antibody-Directed Enzyme Prodrug Therapy
Surinder K. Sharma; R. Barbara Pedley; Jeetendra Bhatia; Geoffrey M. Boxer; Ethaar El-Emir; Uzma Qureshi; Berend Tolner; Helen Lowe; N. Paul Michael; Nigel Minton; Richard H. J. Begent; Kerry A. Chester
Letter to the Editor
Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: Conference Summary Statement
Steven E. Come; Aman U. Buzdar; James N. Ingle; Carlos L. Arteaga; Angela M. Brodie; Graham A. Colditz; Stephen R.D. Johnston; Vessela N. Kristensen; Per E. Lønning; Donald P. McDonnell; C. Kent Osborne; Jose Russo; Richard J. Santen; Douglas Yee; Carol S. Hart
Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival
Mitch Dowsett; Ian E. Smith; Steve R. Ebbs; J. Michael Dixon; Anthony Skene; Clive Griffith; Irene Boeddinghaus; Janine Salter; Simone Detre; Margaret Hills; Susan Ashley; Stephen Francis; Geraldine Walsh; on behalf of the IMPACT Trialists
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.